Unknown

Dataset Information

0

An ultrasensitive electrochemical immunosensor for hepatitis C antibodies based on one-step-eletrosynthetized polypyrrole-graphene nanocomposite.


ABSTRACT: An ultrasensitive label-free electrochemical immunosensor was developed for hepatitis C antibodies (anti-HCV). Worldwide, it is estimated 71 million people have HCV infection in a chronic stage that may lead to cirrose and cancer. To achieve HCV elimination, health programs should include screening testing based on anti-HCV detection allowing the early-stage treatment. The immunosensor was based on a graphene oxide-polypyrrole (PPy-GO) film one-step electropolymerized on the electrode surface. Ultrasensitive anti-HCV detection was ensured by HCV antigen conjugated to biotin that was immobilized in a great amount on streptavidin-coated nanostructured surface. Analytical responses were obtained by anodic peaks from the square wave voltammetry in the presence of ferrocyanide/ferricyanide as a redox probe. This immunosensor exhibited a linear range from 2 to 14 ng mL-1 of anti-HCV and a limit of detection in the clinical range (1.63 ng mL-1). Furthermore, the immunosensor presented an efficient performance for the determination of anti-HCV in spiked serum samples, becoming this developed nanosensor as potential tools for early HCV diagnosis and screening.

Supplementary information

The online version contains supplementary material available at 10.1007/s10853-022-06992-5.

SUBMITTER: Santana GM 

PROVIDER: S-EPMC8882041 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

altmetric image

Publications

An ultrasensitive electrochemical immunosensor for hepatitis C antibodies based on one-step-eletrosynthetized polypyrrole-graphene nanocomposite.

Santana Gilvânia M GM   Silva Anne K S AKS   Foguel Marcos V MV   Dutra Rosa F RF  

Journal of materials science 20220226 9


An ultrasensitive label-free electrochemical immunosensor was developed for hepatitis C antibodies (anti-HCV). Worldwide, it is estimated 71 million people have HCV infection in a chronic stage that may lead to cirrose and cancer. To achieve HCV elimination, health programs should include screening testing based on anti-HCV detection allowing the early-stage treatment. The immunosensor was based on a graphene oxide-polypyrrole (PPy-GO) film one-step electropolymerized on the electrode surface. U  ...[more]

Similar Datasets

| S-EPMC4973229 | biostudies-literature
| S-EPMC10975641 | biostudies-literature
| S-EPMC5301246 | biostudies-literature
| S-EPMC8691096 | biostudies-literature
| S-EPMC9125232 | biostudies-literature
| S-EPMC9064557 | biostudies-literature
| S-EPMC5064308 | biostudies-literature
| S-EPMC8295321 | biostudies-literature
| S-EPMC4754691 | biostudies-literature
| S-EPMC9313248 | biostudies-literature